Abstract | Keywords | Export | Availability | Bookmark

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Bladder cancer is the second most common genitourinary malignancy, with 81,190 estimated new diagnoses in 2018, in the United States alone. Transurethral resection of the bladder and radical cystectomy with bilateral pelvic lymph node dissection constitute the standard treatment for non-muscle invasive or very high-risk non-muscle invasive bladder cancer, respectively. However, survival expectations have not shown to improve in the last 20 years, and new diagnostic and therapeutic tools are urgently needed to improve the outcomes of this potentially lethal disease.

iron deficiency anemia --- fermented goat milk --- brain molecular functions --- neuroprotective effect --- iron supplementation --- pregnancy --- randomized controlled trial --- serum ferritin --- hemoglobin --- iron status --- iron stores --- HFE gene --- iron --- anemia --- kidney --- hepcidin --- erythropoietin --- celiac disease --- gluten-free diet --- iron deficiency --- micronutrient deficiencies --- infant --- breast milk --- formula milk --- high intensity exercise --- ubiquinol --- hematological parameters --- inflammation --- ergogenic effect --- acai --- erythropoiesis --- anaemia --- altitude adjustment --- haemoglobin --- South Africa --- women of reproductive age --- nutritional adequacy --- children --- fermented cow and goat milk --- iron homeostasis --- iron repletion --- gene and protein expression --- redox unbalance --- prematurity --- transfusion --- blood-sparing